Header Logo

Connection

HASHEM EL-SERAG to SEER Program

Back to Details
This is a "connection" page, showing publications HASHEM EL-SERAG has written about SEER Program.
HASHEM EL-SERAG
Connection Strength
1.588
SEER Program
  1. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol. 2007 Jul; 102(7):1377-82.
    View in: PubMed
    Score: 0.240
  2. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA. Dig Dis Sci. 2021 03; 66(3):912-916.
    View in: PubMed
    Score: 0.148
  3. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol. 2012 Jan; 46(1):71-7.
    View in: PubMed
    Score: 0.084
  4. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol. 2011 May; 46(5):597-602.
    View in: PubMed
    Score: 0.078
  5. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009 Jan; 49(1):116-23.
    View in: PubMed
    Score: 0.068
  6. Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol. 2009 Jan; 50(1):10-2.
    View in: PubMed
    Score: 0.067
  7. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol. 2007 Nov-Dec; 41(10):911-7.
    View in: PubMed
    Score: 0.063
  8. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1221-8.
    View in: PubMed
    Score: 0.062
  9. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol. 2007 Sep; 14(9):2519-27.
    View in: PubMed
    Score: 0.061
  10. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006 Jan; 4(1):104-10; quiz 4-5.
    View in: PubMed
    Score: 0.055
  11. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005 Apr; 54(4):533-9.
    View in: PubMed
    Score: 0.052
  12. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005 Jan; 100(1):162-8.
    View in: PubMed
    Score: 0.051
  13. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004 Mar; 40(3):472-7.
    View in: PubMed
    Score: 0.049
  14. Recent Trends in the Incidence of Gastric Cancer in the United States. J Clin Gastroenterol. 2024 01 01; 58(1):39-45.
    View in: PubMed
    Score: 0.048
  15. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003 Nov 18; 139(10):817-23.
    View in: PubMed
    Score: 0.048
  16. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003 Jun; 98(6):1400-9.
    View in: PubMed
    Score: 0.046
  17. Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003 May; 56(5):487-93.
    View in: PubMed
    Score: 0.046
  18. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2002 Jun; 31(2):421-40, viii.
    View in: PubMed
    Score: 0.043
  19. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control. 2021 Apr; 32(4):317-325.
    View in: PubMed
    Score: 0.039
  20. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001 Jan; 33(1):62-5.
    View in: PubMed
    Score: 0.039
  21. Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Dig Dis Sci. 2021 05; 66(5):1669-1672.
    View in: PubMed
    Score: 0.038
  22. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):88-94.
    View in: PubMed
    Score: 0.036
  23. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11; 340(10):745-50.
    View in: PubMed
    Score: 0.034
  24. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013 Aug; 108(8):1314-21.
    View in: PubMed
    Score: 0.023
  25. Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Dig Dis Sci. 2013 Jul; 58(7):2052-60.
    View in: PubMed
    Score: 0.022
  26. The risk of hepatocellular carcinoma in patients with previous malignancy. Cancer Invest. 2008 Jun; 26(5):511-5.
    View in: PubMed
    Score: 0.016
  27. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008 Jan; 103(1):120-7.
    View in: PubMed
    Score: 0.016
  28. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 2007 Aug 01; 110(3):660-9.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.